
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trogocytosis-based generation of suppressive NK cells
Julien Caumartin, Benoı̂t Favier, Marina Daouya, et al.
The EMBO Journal (2007) Vol. 26, Iss. 5, pp. 1423-1433
Open Access | Times Cited: 236
Julien Caumartin, Benoı̂t Favier, Marina Daouya, et al.
The EMBO Journal (2007) Vol. 26, Iss. 5, pp. 1423-1433
Open Access | Times Cited: 236
Showing 1-25 of 236 citing articles:
Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
Theresa Placke, Melanie Örgel, Martin Schaller, et al.
Cancer Research (2011) Vol. 72, Iss. 2, pp. 440-448
Open Access | Times Cited: 386
Theresa Placke, Melanie Örgel, Martin Schaller, et al.
Cancer Research (2011) Vol. 72, Iss. 2, pp. 440-448
Open Access | Times Cited: 386
HLA-G: from biology to clinical benefits
Edgardo D. Carosella, Philippe Moreau, Joël LeMaoult, et al.
Trends in Immunology (2008) Vol. 29, Iss. 3, pp. 125-132
Closed Access | Times Cited: 365
Edgardo D. Carosella, Philippe Moreau, Joël LeMaoult, et al.
Trends in Immunology (2008) Vol. 29, Iss. 3, pp. 125-132
Closed Access | Times Cited: 365
Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association
Eduardo Antônio Donadi, Erick C. Castelli, Antonio Arnaiz‐Villena, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 369-395
Open Access | Times Cited: 352
Eduardo Antônio Donadi, Erick C. Castelli, Antonio Arnaiz‐Villena, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 369-395
Open Access | Times Cited: 352
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Edgardo D. Carosella, Benoı̂t Favier, Nathalie Rouas‐Freiss, et al.
Blood (2008) Vol. 111, Iss. 10, pp. 4862-4870
Open Access | Times Cited: 341
Edgardo D. Carosella, Benoı̂t Favier, Nathalie Rouas‐Freiss, et al.
Blood (2008) Vol. 111, Iss. 10, pp. 4862-4870
Open Access | Times Cited: 341
HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Cancer and Pregnancy: Parallels in Growth, Invasion, and Immune Modulation and Implications for Cancer Therapeutic Agents
Shernan G. Holtan, Douglas J. Creedon, Paul Haluska, et al.
Mayo Clinic Proceedings (2009) Vol. 84, Iss. 11, pp. 985-1000
Open Access | Times Cited: 273
Shernan G. Holtan, Douglas J. Creedon, Paul Haluska, et al.
Mayo Clinic Proceedings (2009) Vol. 84, Iss. 11, pp. 985-1000
Open Access | Times Cited: 273
HLA-G: At the Interface of Maternal–Fetal Tolerance
Leonardo M. R. Ferreira, Torsten Meißner, Tamara Tilburgs, et al.
Trends in Immunology (2017) Vol. 38, Iss. 4, pp. 272-286
Closed Access | Times Cited: 242
Leonardo M. R. Ferreira, Torsten Meißner, Tamara Tilburgs, et al.
Trends in Immunology (2017) Vol. 38, Iss. 4, pp. 272-286
Closed Access | Times Cited: 242
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 135
Nicholas A. Maskalenko, Dmitry Zhigarev, Kerry S. Campbell
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 559-577
Open Access | Times Cited: 135
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li, Rafet Başar, Guohui Wang, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2133-2144
Open Access | Times Cited: 103
Ye Li, Rafet Başar, Guohui Wang, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2133-2144
Open Access | Times Cited: 103
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer
Mohamed S. Hasim, Marie Marotel, Jonathan J. Hodgins, et al.
Science Advances (2022) Vol. 8, Iss. 15
Open Access | Times Cited: 72
Mohamed S. Hasim, Marie Marotel, Jonathan J. Hodgins, et al.
Science Advances (2022) Vol. 8, Iss. 15
Open Access | Times Cited: 72
The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Mechanisms of cellular communication through intercellular protein transfer
Khawaja Ashfaque Ahmed, Jim Xiang
Journal of Cellular and Molecular Medicine (2010) Vol. 15, Iss. 7, pp. 1458-1473
Open Access | Times Cited: 148
Khawaja Ashfaque Ahmed, Jim Xiang
Journal of Cellular and Molecular Medicine (2010) Vol. 15, Iss. 7, pp. 1458-1473
Open Access | Times Cited: 148
Role of non-classical MHC class I molecules in cancer immunosuppression
Grazyna Kochan, David Escors, Karine Breckpot, et al.
OncoImmunology (2013) Vol. 2, Iss. 11, pp. e26491-e26491
Open Access | Times Cited: 146
Grazyna Kochan, David Escors, Karine Breckpot, et al.
OncoImmunology (2013) Vol. 2, Iss. 11, pp. e26491-e26491
Open Access | Times Cited: 146
The HLA-G cycle provides for both NK tolerance and immunity at the maternal–fetal interface
Tamara Tilburgs, J. Henry Evans, Ângela C. Crespo, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 43, pp. 13312-13317
Open Access | Times Cited: 143
Tamara Tilburgs, J. Henry Evans, Ângela C. Crespo, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 43, pp. 13312-13317
Open Access | Times Cited: 143
Chapter 2 Natural Killer Cell Tolerance
A. Helena Jonsson, Wayne M. Yokoyama
Advances in immunology (2009), pp. 27-79
Closed Access | Times Cited: 139
A. Helena Jonsson, Wayne M. Yokoyama
Advances in immunology (2009), pp. 27-79
Closed Access | Times Cited: 139
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Roles of HLA-G in the Maternal-Fetal Immune Microenvironment
Xiuxiu Xu, Yonggang Zhou, Haiming Wei
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 130
Xiuxiu Xu, Yonggang Zhou, Haiming Wei
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 130
Antigen Presentation by MHC-Dressed Cells
M. NAKAYAMA
Frontiers in Immunology (2015) Vol. 5
Open Access | Times Cited: 125
M. NAKAYAMA
Frontiers in Immunology (2015) Vol. 5
Open Access | Times Cited: 125
Minimal PD-1 expression in mouse and human NK cells under diverse conditions
Sean J. Judge, Cordelia Dunai, Ethan G. Aguilar, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 6, pp. 3051-3068
Open Access | Times Cited: 125
Sean J. Judge, Cordelia Dunai, Ethan G. Aguilar, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 6, pp. 3051-3068
Open Access | Times Cited: 125
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 121
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 121
Molecular Pathways: Human Leukocyte Antigen G (HLA-G)
Giuseppe Curigliano, Carmen Criscitiello, Lucia Gelao, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 20, pp. 5564-5571
Closed Access | Times Cited: 120
Giuseppe Curigliano, Carmen Criscitiello, Lucia Gelao, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 20, pp. 5564-5571
Closed Access | Times Cited: 120
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120
Engineering lymph node homing of ex vivo–expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7
Srinivas S. Somanchi, Anitha Somanchi, Laurence J.N. Cooper, et al.
Blood (2012) Vol. 119, Iss. 22, pp. 5164-5172
Open Access | Times Cited: 118
Srinivas S. Somanchi, Anitha Somanchi, Laurence J.N. Cooper, et al.
Blood (2012) Vol. 119, Iss. 22, pp. 5164-5172
Open Access | Times Cited: 118
Innate and Adaptive Immune Interactions at the Fetal–Maternal Interface in Healthy Human Pregnancy and Pre-Eclampsia
Peter Hsu, Ralph Nanan
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 111
Peter Hsu, Ralph Nanan
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 111
Features of Human Decidual NK Cells in Healthy Pregnancy and During Viral Infection
Nabila Jabrane‐Ferrat
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 109
Nabila Jabrane‐Ferrat
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 109